Earnings Beat: Credo Technology reported fourth-quarter results that exceeded expectations, with revenue surging 206 percent year over year and net income climbing fivefold to 662 million dollars. Analysts highlighted the strength of the beat and raised fiscal 2027 guidance, citing accelerating demand in data center connectivity solutions.
Market Reaction: Despite the solid performance, shares fell about 11 percent in after-hours trading, prompting debate over supply-chain constraints at advanced nodes and customer concentration risks. Observers noted the pullback as a potential buying opportunity amid broader sector rotation following recent comments from industry leaders on copper versus optical interconnects.
Analyst Views: Several firms reiterated buy ratings and lifted price targets, underscoring the company's role in the ongoing artificial-intelligence infrastructure buildout. Long-term holders emphasized resilience, pointing to multi-year growth trajectories despite near-term volatility.
Note: This discussion summary was generated from an AI condensation of post data.
Credo Technology Insider Trading Activity
Credo Technology insiders have traded $CRDO stock on the open market 292 times in the past 6 months. Of those trades, 0 have been purchases and 292 have been sales.
Here’s a breakdown of recent trading of $CRDO stock by insiders over the last 6 months:
- CHI FUNG CHENG (Chief Technology Officer) has made 0 purchases and 174 sales selling 617,434 shares for an estimated $89,131,114.
- YAT TUNG LAM (Chief Operating Officer) has made 0 purchases and 13 sales selling 376,360 shares for an estimated $57,323,772.
- WILLIAM JOSEPH BRENNAN (Pres & Chief Executive Officer) has made 0 purchases and 91 sales selling 251,278 shares for an estimated $31,353,762.
- JAMES LAUFMAN (Chief Legal Officer, Secretary) has made 0 purchases and 2 sales selling 20,000 shares for an estimated $3,144,100.
- DANIEL W. FLEMING (Chief Financial Officer) has made 0 purchases and 7 sales selling 21,062 shares for an estimated $2,800,355.
- SYLVIA ACEVEDO has made 0 purchases and 3 sales selling 4,075 shares for an estimated $697,389.
- MANPREET KHAIRA sold 2,000 shares for an estimated $350,000
- PANTAS SUTARDJA, sold 1,875 shares for an estimated $241,256
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Credo Technology Revenue
Credo Technology had revenues of $407M in Q3 2026. This is an increase of 201.49% from the same period in the prior year.
You can track CRDO financials on Quiver Quantitative's CRDO stock page.
You can access data on CRDO stock through the Quiver Quantitative API.
Credo Technology Congressional Stock Trading
Members of Congress have traded $CRDO stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $CRDO stock by members of Congress over the last 6 months:
- SENATOR MARKWAYNE MULLIN has traded it 3 times. They made 0 purchases and 3 sales worth up to $150,000 on 02/04, 12/18.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 01/20.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
Credo Technology Hedge Fund Activity
We have seen 433 institutional investors add shares of Credo Technology stock to their portfolio, and 438 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CORIENT PRIVATE WEALTH LLC removed 3,596,199 shares (-99.9%) from their portfolio in Q1 2026, for an estimated $337,575,200
- PRICE T ROWE ASSOCIATES INC /MD/ removed 2,424,856 shares (-63.6%) from their portfolio in Q1 2026, for an estimated $227,621,232
- SRS INVESTMENT MANAGEMENT, LLC added 2,394,163 shares (+2143.8%) to their portfolio in Q1 2026, for an estimated $224,740,080
- POINT72 ASSET MANAGEMENT, L.P. added 1,916,943 shares (+34.5%) to their portfolio in Q1 2026, for an estimated $179,943,439
- JPMORGAN CHASE & CO removed 1,904,946 shares (-24.7%) from their portfolio in Q4 2025, for an estimated $274,102,679
- D. E. SHAW & CO., INC. removed 1,680,028 shares (-51.9%) from their portfolio in Q4 2025, for an estimated $241,739,228
- JANUS HENDERSON GROUP PLC added 1,422,391 shares (+841.9%) to their portfolio in Q4 2025, for an estimated $204,667,840
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Credo Technology Analyst Ratings
Wall Street analysts have issued reports on $CRDO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Rothschild & Co issued a "Buy" rating on 05/01/2026
To track analyst ratings and price targets for Credo Technology, check out Quiver Quantitative's $CRDO forecast page.
Credo Technology Price Targets
Multiple analysts have issued price targets for $CRDO recently. We have seen 11 analysts offer price targets for $CRDO in the last 6 months, with a median target of $252.0.
Here are some recent targets:
- N. Quinn Bolton from Needham set a target price of $275.0 on 06/02/2026
- Vijay Rakesh from Mizuho set a target price of $290.0 on 06/02/2026
- Mike Genovese from Rosenblatt set a target price of $215.0 on 06/02/2026
- Vivek Arya from B of A Securities set a target price of $252.0 on 06/02/2026
- Blayne Curtis from Jefferies set a target price of $270.0 on 06/02/2026
- Sean O'Loughlin from TD Cowen set a target price of $260.0 on 06/02/2026
- Christopher Rolland from Susquehanna set a target price of $235.0 on 06/02/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.